Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitor has been reported to have kidney-protective benefits. To elucidate how antidiabetic agents prevent diabetic kidney disease progression, it is important to investigate their effect on the kidney environment in type 2 diabetes mellitus (DM) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Nam-Jun, Kim, Dae-Yeon, Kwon, Soon Hyo, Ha, Tae Won, Kim, Hyun Kyu, Lee, Man Ryul, Chun, Sung Wan, Park, Samel, Lee, Eun-young, Gil, Hyo-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Nephrology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476296/
https://www.ncbi.nlm.nih.gov/pubmed/34233436
http://dx.doi.org/10.23876/j.krcp.21.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476296/
https://www.ncbi.nlm.nih.gov/pubmed/34233436
http://dx.doi.org/10.23876/j.krcp.21.015

Ejemplares similares